The influence of Epstein-Barr virus (EBV) on cancer is not well understood. High-throughput sequencing of nasopharyngeal carcinoma (NPC) illustrates the influences of EBV on oncogenesis and identifies driver pathways that might be therapeutically useful for NPC treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
zur Hausen, H. et al. Nature 228, 1056–1058 (1970).
Lin, D. et al. Nat. Genet. 46, 866–871 (2014).
Niedobitek, G. Mol. Pathol. 53, 248–254 (2000).
Wang, K. et al. Nat. Genet. 43, 1219–1223 (2011).
Lin, J.C. et al. N. Engl. J. Med. 350, 2461–2470 (2004).
Chung, G.T. et al. J. Pathol. 231, 158–167 (2013).
Valouev, A. et al. Genome Res. 24, 300–309 (2014).
Liu, P. et al. J. Virol. 85, 11291–11299 (2011).
Shuda, M. et al. Proc. Natl. Acad. Sci. USA 105, 16272–16277 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
West, R. Fingerprints of Epstein-Barr virus in nasopharyngeal carcinoma. Nat Genet 46, 809–810 (2014). https://doi.org/10.1038/ng.3038
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3038